**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 288-32-4 |Imidazole | 99 | 206-019-2 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: C
Risk Phrases: 22 34
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. Causes burns.
Potential Health Effects
Eye:
Contact with eyes may cause severe irritation, and possible eye
burns.
Skin:
Exposure may cause irritation and possible burns. May be absorbed
through the skin. The severity of injury depends on the
concentration of the solution and the duration of exposure.
Ingestion:
Harmful if swallowed. Causes digestive tract irritation with
possible burns.
Inhalation:
Causes respiratory tract irritation with possible burns.
Chronic:
Laboratory experiments have resulted in mutagenic effects. May cause
adverse reproductive effects. Animal evidence suggests that
fetotoxicity and teratogenicity may be observed at doses that also
cause harmful effects in the mothers.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
In case of contact, immediately flush eyes with plenty of water for
at least 15 minutes. Get medical aid immediately.
Skin:
In case of contact, immediately flush skin with plenty of water for
at least 15 minutes while removing contaminated clothing and shoes.
Get medical aid immediately. Wash clothing before reuse.
Ingestion:
If swallowed, do NOT induce vomiting. Get medical aid immediately.
If victim is fully conscious, give a cupful of water. Never give
anything by mouth to an unconscious person.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial
respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Dusts at sufficient concentrations can form
explosive mixtures with air. During a fire, irritating and highly
toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Minimize dust generation and accumulation. Do not
get in eyes, on skin, or on clothing. Keep container tightly closed.
Do not breathe dust. Use only with adequate ventilation.
Storage:
Store in a tightly closed container. Keep from contact with
oxidizing materials. Store in a cool, dry, well-ventilated area away
from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 288-32-4:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystalline powder
Color: white to beige
Odor: amine-like
pH: Weak base (aq. sol.)
Vapor Pressure: 0.046 mm Hg @ 25 deg C
Viscosity: Not available.
Boiling Point: 255-256 deg C
Freezing/Melting Point: 86-90 deg C
Autoignition Temperature: 480 deg C ( 896.00 deg F)
Flash Point: 145 deg C ( 293.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Soluble.
Specific Gravity/Density: Not available.
Molecular Formula: C3H4N2
Molecular Weight: 68.08
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 288-32-4: NI3325000
LD50/LC50:
CAS# 288-32-4: Oral, mouse: LD50 = 880 mg/kg; Oral, rat: LD50 = 220
mg/kg.
Carcinogenicity:
Imidazole -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: CORROSIVE SOLID, BASIC, ORGANIC, N.O.S.*
Hazard Class: 8
UN Number: 3263
Packing Group: III
IMO
Shipping Name: CORROSIVE SOLID, BASIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3263
Packing Group: III
RID/ADR
Shipping Name: CORROSIVE SOLID, BASIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3263
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 22 Harmful if swallowed.
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 288-32-4: 1
Canada
CAS# 288-32-4 is listed on Canada's DSL List.
CAS# 288-32-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 288-32-4 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 6/28/1999 Revision #5 Date: 3/22/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2-(Piperidylmethyl)-1-Cyclohexanone Hydrochloride, 98%
| 6966-09-2 |
|
Fluorosilicic Acid (25 Wt % Aqueous Solution)
| 7732-18-5 |
|
(S)-(-)-Bupivacaine hydrochloride, 99%
| 27262-48-2 |
|
6,7-Diethoxy-3,4-Dihydroisoquinoline-1(2H)-Thione, 98%
| 0-01-1 |
|
Sodium phosphate, dibasic anhydrous, reagent ACS
| 7558-79-4 |
|
1-Nonanol
| 143-08-8 |
|
2-Acetyl-6,7-Dimethoxy-1-Methylene-1,2,3,4-Tetrahydroisoquinoline,
| 57621-04-2 |
|
Lithium methoxide, 10% solution in methanol
| 865-34-9 |
|
[(3S)-4-Azabicyclo[4.4.0]Dec-3-yl]-N-(Tert-Butyl)Carboxamide, 99%
| 136465-81-1 |
|
C-Benzylcalix(4)resorcinarene
| 0-01-1 |
|
(S)-(-)-2-(2'-Carbomethoxyethyl)-2-Methyl-Cyclohexanone, 98.5+%
| 112898-44-9 |
|
(S)-(-)-alpha-Amino-gamma-butyrolactone hydrochloride, 98%
| 2185-03-7 |
|
N-Benzylmaleimide
| 1631-26-1 |
|
4-(Methylamino)benzoic acid, 97%
| 10541-83-0 |
|
Ethyl (3S)-3-Hydroxybutyrate, 99%
| 56816-01-4 |
|
Hydrofluoric Acid (48-51%), Reagent ACS
| 7664-39-3 |
|
ETHYL (1R,2S)-2-HYDROXYCYCLOHEXANECARBOXYLATE
| 61586-78-5 |
|
Iodic Acid, Reagent ACS (Crystals), 99.5% (Titr.)
| 7782-68-5 |
|
3-Pyrazolidinone Hydrochloride
| 1752-88-1 |
|
Tritylphenol
| 978-86-9 |
|
4-Hydroxy-2-Methoxybenzaldehyde, 98%
| 18278-34-7 |
|
4-Nitrobiphenyl, 98%
| 92-93-3 |
|
6-Iodo-2-picolin-5-ol, 97%
| 23003-30-7 |
|
Ethyl
| 100491-29-0 |
|
D(+)-Carnitine, 98%
| 541-14-0 |
|
D(+)-Carnitinenitrile Chloride, 97%
| 0-01-1 |
|
5-Amino-o-Cresol, 97%
| 2835-95-2 |
|
Hydrogen Peroxide (30% in Water) (Without Stabilizer), Reagent ACS
| 7722-84-1 |
|
4-Amino-o-Cresol, 97%
| 2635-95-2 |
|
Hydroquinone, p.a.
| 123-31-9 |
|
2,3-Difluoro-6-nitrophenol, 97%
| 82419-26-9 |
|
Hydroxylamine Sulfate, 99%
| 10039-54-0 |
|
Hypophosphorous Acid, 50 wt% Solution in Water
| 7732-18-5 |
|
cis-2-Heptene, 97%
| 6443-92-1 |
|
Imidazole
| 288-32-4 |
|
3-Amino-3-Cyclohexylpropionic Acid, 98%
| 129042-71-3 |
|
3-Fluorophenylacetic Acid, 98%(GC)
| 331-25-9 |
|
3-Benzylaminobutyric Acid, 98%
| 14676-01-8 |
|
4-NITROTHIOPHENOL, TECH., 80+%
| 1849-36-1 |
|
ALPHA,ALPHA-DIPHENYLGLYCINE, 98%
| 3060-50-2 |
|
Zirconium(IV) ethoxide, 99%
| 18267-08-8 |
|
Celite high-purity analytical grade
| 61790-53-2 |
|
2-CYANOETHYLHYDRAZINE, 98%
| 353-07-1 |
|
Pentamethylbenzaldehyde, 96%
| 17432-38-1 |
|
4-Chloro-3-nitrobenzenesulfonic acid, sodium salt, 98% (tlc)
| 17691-19-9 |
|
cis-2-Benzylaminomethyl-1-Cyclohexanol Hydrochloride, 98%
| 77612-17-0 |
|
Iron, electrolytically reduced, reagent (powder)
| 7439-89-6 |
|
1-(Gamma-Hydroxypropyl)-6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline
| 0-01-1 |
|
Iron (III) Oxide, 99.999%, -100 Mesh
| 1309-37-1 |
|
Perfluoroadipic acid hydrate, 98%
| 123334-02-1 |
|
|